RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA

This recall is currently active, issued January 1, 2025. It was issued by Remedyrepack Inc..

Company
Remedyrepack Inc.
Recall Initiated
December 2, 2024
Posted
January 1, 2025
Recall Number
D-0165-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 1,564 cards, b) 799 bottles
Firm Location
Indiana, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.

Distribution

Nationwide in the US

Lot / Code Info

a) NDC 70518-0937-04, Lot # J0786744-061724, Exp. 06/30/2025 b) NDC 70518-0937-03, Lot # B3002625-060524, Exp. 10/31/2025

More recalls by Remedyrepack Inc.

View all recalls by this company →

Other recent Class II Drug recalls